In a huge sigh of relief, India has been a big success in the discovery of the Coronavirus vaccine. A vaccine made entirely in the country is ready. The clinical trial of the 'COVAXIN' vaccine made in Indian Council of Medical Research i.e. ICMR and Bharat Biotech International Ltd joint venture will be on 'Priority'. A dozen institutes have been selected for the clinical trials of the BBV152 Covid vaccine. According to the ICMR, after all the trials, the vaccine is set to be launched on August 15, the Independence Day.
The indigenous vaccine is produced from a strain of SARS-CoV-2 isolated by the ICMR-National Institute of Virology.
12 institutes have been selected for the trial of indigenous Kovid vaccine. These include New Delhi, Visakhapatnam, Patna, Belgaum (Karnataka), Nagpur, Gorakhpur, Hyderabad, Aryanagar, Kanpur, Goa and Kattankulathur (Tamil Nadu).
Now clinical trials of this vaccine will begin. Institutes selected by ICMR have been told that the final outcome of this vaccine will depend on their cooperation. These institutes have been shown to show a rapid increase in approvals related to clinical trials.
ICMR has ordered that if institutes are negligent, they will be taken seriously. It has been suggested that the trials should be completed at the highest priority within the stipulated time.
Coronavirus has infected more than 10 million people worldwide so far. It has already had more than 6 lakh cases in India. Researchers around the world are running a race for vaccination of this deadly virus.
More than 125 hundred vaccines are being developed worldwide. Some are being tried on humans and some are in the initial trials. There is not a single vaccine yet approved for commercial use for Covid-19.